NEW YORK, May 25, 2021 /PRNewswire/ — CEFALY Technology today announced the release of the new CEFALY DUAL Enhanced, the next-generation model of the dual-purpose, external Trigeminal Nerve Stimulator ...

The first dual-purpose, external trigeminal nerve stimulation device to treat and prevent acute migraine is now available over-the-counter to adults over age 18. The US Food and Drug Administration ...

Cefaly smaller anti-migraine device Previously, the external trigeminal nerve stimulator was only available with a prescription. The Food and Drug Administration (FDA) has cleared Cefaly Dual (Cefaly ...

Please provide your email address to receive an email when new articles are posted on . Cefaly Technology’s nerve stimulation device, when compared with sham stimulation, was more effective in ...

The Buy Back allows CEFALY users to trade up their device for a smaller, sleeker, device with two migraine treatment programs, rechargeable battery, and a renewed 60-day money back guarantee NEW YORK, ...

During the past decade, noninvasive neuromodulation devices have become an integral part of the migraine treatment toolkit, with Cefaly leading the charge. Currently, six such devices — each having a ...

First Real-World, Randomized, Sham-Controlled Clinical Trial of 2-Hour External Trigeminal Nerve Stimulation (e-TNS) in Finds That the e-TNS CEFALY Device Is Effective in Treating Acute Migraine Pain ...

NEW YORK, Sept. 26, 2018 /PRNewswire/ -- Two new scientific published articles in the peer-reviewed magazine of the International Headache Society, confirm the basic mechanism of the Cefaly® device ...

DARIEN, Conn., Dec. 20, 2022 /PRNewswire/ -- Medical device maker CEFALY Technology has announced that owners of older CEFALY devices can trade them in for credit toward the purchase of the all-new ...